The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery

Area of Science:

• Biomedical research
• Drug discovery and development
• Oncology

Background:

• Phenotypic drug discovery (PDD) is experiencing a resurgence in pharmaceutical research.
• PDD involves screening compounds for desired effects without prior target identification.
• Traditional animal models often fail to predict human therapeutic responses due to physiological differences.

Purpose of the Study:

• To review the reemergence of PDD in drug development.
• To highlight the potential of porcine models in cancer research.
• To present precision medicine-based swine cancer models.

Main Methods:

• Review of existing literature on PDD and animal models.
• Analysis of anatomical, physiological, metabolic, and genetic similarities between pigs and humans.
• Discussion of genetically defined swine cancer models.

Main Results:

• Porcine models demonstrate higher predictive value for human therapeutic outcomes than rodents.
• Pigs offer a suitable platform for cancer research due to human-like biological characteristics.
• Genetically defined swine cancer models are being developed for precision medicine.

Conclusions:

• PDD's renewed application can enhance therapeutic development.
• Porcine models show significant promise for improving pre-clinical cancer drug discovery and testing.
• Precision swine cancer models represent a valuable tool for biomedical research.